Cofactor Genomics Announces New U.S. Patent Granted for Predictive Immune Modeling Technology
SAN FRANCISCO, Calif. – August 20, 2020 – Cofactor Genomics, the company bridging the precision medicine gap, announced today that the United States Patent and Trademark Office (USPTO) has granted Patent No. 10636512 protecting the Company’s predictive immune modeling technolo...
Cofactor Genomics Awards Grants to Research Teams for New T Cell State Characterization Technology
San Francisco, CA – May 6, 2020 – Winners of Cofactor Genomics’ “Functional to FFPE” Grant Program were publicly announced today. Two projects from Dell Medical School at University of Texas and the University Hospital in Basel were chosen based on their potential to make a s...
Analytical Validation of Cofactor Genomics’ Immune Profiling Assay Published in Journal of Molecular Diagnostics
SAN FRANCISCO, Calif. – April 16, 2020 – Today, Cofactor Genomics announced the peer-reviewed publication of an analytical validation study demonstrating the performance of its novel RNA-based immune profiling assay, ImmunoPrism®, in the April 2020 issue of the Journal of Mole...